Paloma Partners Management CO Puma Biotechnology, Inc. Transaction History

Paloma Partners Management CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$7.78 - $12.13 $241,366 - $376,321	-31,024 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.5 - $11.14 $294,728 - $345,607	31,024 New	31,024 $313,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $189,693 - $440,101	-30,206 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $196,339 - $324,110	30,206 New	30,206 $265,000
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $141,646 - $411,812	-11,516 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $239,187 - $487,932	11,516 New	11,516 $447,000

100

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $110M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.